Medicare Wastes $3.6 Billion Annually on Low-Value Care, Study Finds
New study reveals Medicare spends $3.6 billion annually on low-value medical services, with $800M in patient costs. Policy changes could reduce waste and improve value.
CMS Proposes 2026 Medicare Physician Fee Schedule With Focus on Value and Telehealth
CMS's 2026 Medicare Physician Fee Schedule proposal emphasizes value-based payment increases, expanded telehealth flexibilities, new chronic care payment models, and significant Medicare spending reductions for skin substitutes.
Legislative Changes Delay Medicare Drug Price Negotiations for Expensive Cancer Medications
Recent Republican-led legislative changes delay Medicare drug price negotiations for costly cancer treatments, maintaining high patient costs and impacting seniors and disabled Americans.
CMS Medicare Learning Network Web-Based Training Supports Provider Education
CMS offers a range of Medicare Learning Network web-based training courses for providers covering billing, coding, fraud prevention, and compliance. Courses are self-paced but do not provide continuing education credits. Subscribe to MLN Connects® for updates.
YAML-in-HTML Enhances AI-Readable Insurance Data on the Web
YAML-in-HTML embeds structured, trust-scored insurance data into web pages enhancing AI understanding and regulatory compliance for Medicare Advantage plans.
Growing Network of U.S. Health System-Owned Insurance Plans Enhances Integrated Care
An overview of expanding health system-owned insurance plans across the U.S. highlighting integrated care, diverse product offerings, and enhanced provider networks.
Exact Sciences’ Growth Potential Bolstered by Cologuard Plus and Medicare Advantage Expansion
Exact Sciences gains Buy ratings as Cologuard Plus expands in-network Medicare Advantage coverage, boosting reimbursement and revenue potential in cancer screening diagnostics.
CMS Revisits GLP-1 Drug Coverage for Obesity in Medicare, Medicaid Pilot
CMS is considering a pilot program to cover GLP-1 drugs for obesity under Medicare and Medicaid, reversing earlier policy. This evolving coverage changes obesity drug access for patients and payers.
Trump Administration Proposes Medicare, Medicaid Pilot for GLP-1 Weight Loss Drugs
The Trump administration proposes a Medicare and Medicaid pilot program for covering GLP-1 weight loss drugs, marking a key shift in healthcare policy and potential budget impacts.
Medicare 2026 Rate Increases, Hospital Efficiency Push, and AI Advances in Healthcare
Explore the 2026 Medicare payment updates for hospice, rehab, and psychiatric care, hospital efficiency initiatives amid rising costs, and growing use of agentic AI in healthcare settings.